Can Amiodarone be administered with digoxin (Digitalis glycoside)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Amiodarone Be Given With Digoxin?

Yes, amiodarone can be administered with digoxin, but the digoxin dose must be reduced by 50% when amiodarone is initiated, and plasma digoxin levels require close monitoring to prevent toxicity. 1

Mechanism of Drug Interaction

The interaction between these medications is clinically significant and predictable:

  • Digoxin levels consistently double after coadministration with amiodarone due to inhibition of digoxin secretion from renal tubules and P-glycoprotein membrane transporter system blockade 1, 2
  • Amiodarone reduces total body clearance of digoxin by approximately 29% and nonrenal clearance by 33% 3
  • The elimination half-life of digoxin is prolonged by approximately 31% when combined with amiodarone 3

Required Dose Adjustments

When initiating amiodarone in patients already taking digoxin:

  • Reduce digoxin dose by 50% immediately when amiodarone is started 1, 2
  • For IV digoxin loading during amiodarone infusion, reduce the standard loading dose by 30-50% to approximately 0.125-0.35 mg IV bolus 4
  • For maintenance therapy, reduce the standard maintenance dose by 30-50% based on the patient's age, weight, and renal function 4, 2

Special considerations for Japanese patients with atrial fibrillation and heart failure:

  • For patients with creatinine clearance >30 mL/min taking amiodarone: use digoxin 0.0625 mg daily 5
  • For patients with creatinine clearance ≤30 mL/min and N-desethylamiodarone concentration >600 ng/mL: use digoxin 0.03125 mg daily 5

Mandatory Monitoring Protocol

Baseline assessment before combining medications:

  • Obtain baseline digoxin level before starting amiodarone 1
  • Check renal function (creatinine clearance) as this significantly affects digoxin clearance 4, 5

Ongoing monitoring requirements:

  • Check digoxin levels at baseline, during loading phase, and every 6 months during maintenance therapy 1
  • Monitor more frequently when initiating or adjusting amiodarone therapy 4
  • Target trough serum digoxin level: 0.5-1.0 ng/mL (levels >2 ng/mL are associated with toxicity, though symptoms may occur at lower levels) 1, 4
  • Monitor for signs of digoxin toxicity including gastrointestinal symptoms (nausea, vomiting), neurological symptoms (confusion, visual disturbances), and cardiac arrhythmias 4, 3

Clinical Toxicity Risk

The combination carries substantial risk if not properly managed:

  • In one study of 28 patients, gastrointestinal side effects occurred in 9 patients (32%), central nervous system reactions in 5 patients (18%), and cardiovascular reactions in 4 patients (14%) when amiodarone was added to digoxin therapy 3
  • Digoxin toxicity commonly occurs with serum levels >2 ng/mL but may occur at lower levels if hypokalemia, hypomagnesemia, or hypothyroidism coexist 6

Absolute Contraindications and Precautions

Do not use this combination in patients with:

  • Second or third-degree heart block without a pacemaker 1, 4
  • Significant sinus or atrioventricular block unless treated with a permanent pacemaker 6
  • Wolff-Parkinson-White syndrome with atrial fibrillation/flutter 1, 4

Use with extreme caution in:

  • Renal dysfunction (requires further dose reduction) 1, 4, 5
  • Pre-existing AV block or SA node dysfunction 1, 4
  • Patients receiving other drugs with SA and/or AV nodal-blocking properties 1

Common Pitfalls to Avoid

  • Never continue full-dose digoxin when starting amiodarone - this predictably leads to toxic digoxin levels 1
  • Do not assume the interaction is immediate; amiodarone has a long half-life, so interactions can develop gradually and persist after discontinuation 2
  • Avoid grapefruit juice in patients taking amiodarone, as it increases amiodarone levels by 50% and can indirectly worsen the digoxin interaction 1, 2
  • Remember that N-desethylamiodarone (the active metabolite) contributes significantly to the interaction, particularly in reducing digoxin clearance 5

References

Related Questions

Can a patient taking amiodarone (antiarrhythmic medication) be given digoxin (digitalis glycoside)?
What is the recommended dose of digoxin (digitalis glycoside) in a patient receiving an amiodarone (antiarrhythmic medication) infusion?
Is it safe to use amiodarone and digoxin (digitalis glycoside) together?
Can Amiodarone (antiarrhythmic medication) infusion be given alongside Digoxin (digitalis glycoside) for controlling Atrial Fibrillation?
Can a digoxin load be given to a patient on amiodarone (Amio)?
Is the current dosing of warfarin (Warfarin) still appropriate for a patient with a mechanical heart valve and a target International Normalized Ratio (INR) range of 2.5 to 3.5?
What is the best approach to manage an 8-year-old patient with autism, attention deficit hyperactivity disorder (ADHD), anxiety, depression, mood dysregulation, and self-injurious behaviors, who is currently on multiple medications?
What is the management plan for a patient with a possible small apical infarct (myocardial infarction) versus artifact, no significant reversible defect or ischemia, and normal left ventricular (LV) systolic function?
What is the recommended dose of penicillin (Penicillin V potassium) for a teenager with streptococcal pharyngitis (strep throat)?
What is the difference between Cardizem CD (diltiazem) and Tiazac (diltiazem)?
What is the potential timeline for the onset of Subacute Sclerosing Panencephalitis (SSPE) if it were hypothetically linked to the Measles, Mumps, and Rubella (MMR) vaccine?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.